Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Cierpicki, Tomasz

Class:IdPerson:9036531
_displayNameCierpicki, Tomasz
_timestamp2018-02-03 06:29:43
created[InstanceEdit:9036505] Shamovsky, Veronica, 2018-02-03
firstnameTomasz
initialT
surnameCierpicki
(author)[LiteratureReference:9036508] Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding
[LiteratureReference:9675242] An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain
[LiteratureReference:9818941] Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias
[Change default viewing format]
No pathways have been reviewed or authored by Cierpicki, Tomasz (9036531)